Radiopharmaceuticals and Lung Cancer

Podcast | English | 2024 | 54 Min

Create Account

Cost

$0.00

Credit

No Credit Offered

This episode of Lung Cancer Considered focuses on radiopharmaceuticals-- a unique class of drugs that may have the most immediate impact in neuroendocrine tumors. Host Dr. Stephen Liu leads a discussion with three respected international clinicians about how these therapies play a role in both diagnostics and therapeutics and how they may soon be expanding.

Podcast Hosts:

Stephen Liu, MD, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C., USA

Podcast Guests:

Aman Chauhan, MD, Assistant Professor of Medicine, Leader of the Neuroendrocrine Tumor Program and Co-Director of the Theranostic Program, University of Miami, Miami, FL, USA
Jaydira Del Rivero, MD, Associate Research Physician and Physician Scientist in the Developmental Therapeutics Branch, Director of the Neuroendocrine Tumor Program, National Cancer Institute, Bethesda, Maryland, USA
Ken Herrmann, MD, Chair of the Department of Nuclear Medicine, Universitatsmedizin Essen, Past Chair of the European Association of Nuclear Medicine Oncology & Theranostics Committee, Essen, Germany